Quest Diagnostics is pleased to announce that we now offer an EtG (Ethyl glucuronide) screening panel. The immunoassay screening test used for EtG, in this new panel, is not currently FDA 510(K) listed, and results are intended exclusively for criminal justice, child welfare and other court-related testing. The panel uses a urine sample to screen for metabolites of alcohol (ethanol) and can be a valuable resource for case managers, parole officers and child/family services professionals.
Alcohol is a psychoactive drug found in beer, wine and spirits and has a depressant effect. According to the National Council on Alcoholism and Drug Dependence, Inc., alcohol is the most commonly used addictive substance in the U.S., with one in every 12 adults suffering from alcohol abuse or dependence. Sadly, an estimated 7 million children live in a household where at least one parent is dependent on or has abused alcohol.
EtG testing is typically used to evaluate and monitor whether an individual is abstaining from the consumption of alcohol. Our EtG testing protocol uses an immunoassay screen with LC/MS/MS confirmation of any presumptive positives. EtS testing is also performed as a part of the confirmatory testing. This process maximizes the benefits of both the sensitivity of EtG testing and the apparent stability of EtS as a separate long-term ethanol metabolite.